Find clinical trials for Endometrial Cancer in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near Seattle, WA, USA:
A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer...
Phase 2
Seattle, Washington, United States and 8 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Seattle, Washington, United States and 202 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Seattle, Washington, United States and 162 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Seattle, Washington, United States and 73 other locations
in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), platinum-re ...
Phase 1
Seattle, Washington, United States of America and 17 other locations
in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...
Phase 1, Phase 2
Seattle, Washington, United States and 66 other locations
The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.
Phase 1
Seattle, Washington, United States and 22 other locations
Phase 1, first-in-human, open label study of CAR macrophages in HER2 overexpressing solid tumors....
Phase 1
Seattle, Washington, United States and 6 other locations
This clinical trial is studying advanced or metastatic solid tumors. Once a solid tumor has grown very large in one spot or has spr ...
Phase 2
Seattle, Washington, United States and 48 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Seattle, Washington, United States and 59 other locations
Clinical trials
Research sites
Resources
Legal